Published in J Thorac Cardiovasc Surg on February 01, 2003
Multicenter bridge to transplantation with the HeartMate assist device: evaluation from another perspective. J Thorac Cardiovasc Surg (2003) 5.03
Multicenter bridge to transplantation with the HeartMate assist device: evaluation from another perspective. J Thorac Cardiovasc Surg (2003) 5.03
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med (2007) 7.15
Sinus of Valsalva aneurysm or fistula: management and outcome. Ann Thorac Surg (1999) 4.78
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J (2004) 3.70
Primary cardiac sarcomas. Ann Thorac Surg (1991) 3.61
Salvage of infected left ventricular assist device with antibiotic beads. Plast Reconstr Surg (2014) 3.28
Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation (2012) 3.24
Metabolic gene expression in fetal and failing human heart. Circulation (2001) 2.59
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation (2007) 2.34
Surgical treatment of cardiac tumors: a 25-year experience. Ann Thorac Surg (1990) 2.34
Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting. Ann Thorac Surg (1989) 2.17
Device-supported myocardial revascularization: safe help for sick hearts. Ann Thorac Surg (1992) 2.06
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation (1997) 2.00
Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail (2005) 1.99
Complete resection of a right atrial intracavitary metastatic melanoma. Ann Thorac Surg (1996) 1.95
A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure. J Am Coll Cardiol (2011) 1.71
Coronary artery bypass for unsuccessful percutaneous transluminal coronary angioplasty. J Thorac Cardiovasc Surg (1984) 1.71
Extension of donor criteria in cardiac transplantation: surgical risk versus supply-side economics. Ann Thorac Surg (1990) 1.69
First permanent implant of the Jarvik 2000 Heart. Lancet (2000) 1.68
Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med (1989) 1.67
Bedside right ventricular assist device removal in the conscious patient. Ann Thorac Surg (2007) 1.63
End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transplant (2007) 1.60
Bacterial mediastinitis after heart transplantation. J Heart Lung Transplant (1992) 1.56
Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg (2004) 1.54
Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Ann Thorac Surg (2008) 1.54
Flail tricuspid leaflet after multiple biopsies following orthotopic heart transplantation: echocardiographic and hemodynamic correlation. J Heart Lung Transplant (1994) 1.52
Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant (2005) 1.51
Advanced heart failure: feasibility study of long-term continuous axial flow pump support. Eur Heart J (2005) 1.49
Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant (2005) 1.48
Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant (2005) 1.47
Atrial fibrillation after cardiac transplantation: experience in 498 consecutive cases. Ann Thorac Surg (2008) 1.46
Patent foramen ovale: a cause of hypoxemia in patients on left ventricular support. Ann Thorac Surg (1991) 1.45
Cardiac tumors. Clinical spectrum and prognosis of lesions other than classical benign myxoma in 20 patients. J Thorac Cardiovasc Surg (1984) 1.43
Effect of pump flow mode of novel left ventricular assist device upon end organ perfusion in dogs with doxorubicin induced heart failure. ASAIO J (2005) 1.41
Thrombogenicity of mechanical aortic valves in an animal model: site specific testing is crucial. ASAIO J (2004) 1.39
TandemHeart as a rescue therapy for patients with critical aortic valve stenosis. Ann Thorac Surg (2009) 1.39
Lung cancer after heart transplantation: a 17-year experience. Ann Thorac Surg (2005) 1.39
Cardiac transplantation in Puerto Rican patients at the Texas Heart Institute. Bol Asoc Med P R (1991) 1.39
Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant (2011) 1.38
Preclinical assessment of a trileaflet mechanical valve in the mitral position in a calf model. Ann Thorac Surg (2004) 1.38
The AbioCor implantable replacement heart. Ann Thorac Surg (2003) 1.38
Initial clinical experience of total cardiac replacement with dual HeartMate-II axial flow pumps for severe biventricular heart failure. Methodist Debakey Cardiovasc J (2011) 1.37
The use of pyloric exclusion in the management of severe duodenal injuries. Am J Surg (1977) 1.36
Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology (2002) 1.33
Human cardiac explantation and autotransplantation: application in a patient with a large cardiac pheochromocytoma. Tex Heart Inst J (1985) 1.29
A system for grading cardiac allograft rejection. Tex Heart Inst J (1986) 1.25
Acquired commissural fusion of aortic valves in patients with left ventricular assist devices. J Heart Lung Transplant (2003) 1.22
Post-operative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: multi-institutional study of post-operative weight change. J Heart Lung Transplant (2005) 1.21
Hemodynamics and patient safety during pump-off studies of an axial-flow left ventricular assist device. J Heart Lung Transplant (2006) 1.19
Effects of perfusion mode on regional and global organ blood flow in a neonatal piglet model. Ann Thorac Surg (1999) 1.18
Pulsatile and nonpulsatile flows can be quantified in terms of energy equivalent pressure during cardiopulmonary bypass for direct comparisons. ASAIO J (2000) 1.13
Intrapericardial pheochromocytoma. Am J Med (1983) 1.13
Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery. Circulation (1999) 1.13
Monitoring regional cerebral oxygen saturation using near-infrared spectroscopy during pulsatile hypothermic cardiopulmonary bypass in a neonatal piglet model. ASAIO J (2000) 1.13
Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support. J Heart Lung Transplant (2004) 1.12
Coronary artery revascularization without cardiopulmonary bypass. Tex Heart Inst J (1984) 1.11
Chronic in vivo evaluation of an electrohydraulic total artificial heart. ASAIO J (1996) 1.11
Cardiac transplantation in an 8-month-old female infant with subendocardial fibroelastosis. JAMA (1986) 1.10
Right hydrothorax after left subclavian and internal jugular vein catheterization: a delayed complication. Tex Heart Inst J (1985) 1.10
Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation (1994) 1.09
Early and late results of coronary endarterectomy. Analysis of 3,369 patients. J Thorac Cardiovasc Surg (1986) 1.09
Surgical treatment of mitral systolic click syndrome: results in 37 patients. Ann Thorac Surg (1985) 1.08
Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency. Tex Heart Inst J (1994) 1.07
Left ventricular assist devices: an alternative to medical therapy for end-stage heart failure. Curr Opin Cardiol (2003) 1.07
Defining pulsatile perfusion: quantification in terms of energy equivalent pressure. Artif Organs (1999) 1.07
Sinus venosus atrial septal defect: early and late results following closure in 109 patients. Ann Thorac Surg (1978) 1.06
Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant (2001) 1.06
Infectious complications associated with ventricular assist systems. ASAIO J (2001) 1.06
Fibrosis and heart failure. Heart Fail Rev (2014) 1.05
Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey. Circulation (1991) 1.04
Congenital diverticulum of the ventricle. J Thorac Cardiovasc Surg (1986) 1.04
In vivo evaluation of the HeartWare centrifugal ventricular assist device. Tex Heart Inst J (2007) 1.04
Infection after cardiac transplantation: treatment and prognosis. Tex Heart Inst J (1984) 1.02
The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge). Tex Heart Inst J (2008) 1.02
Left atrial metastasis from hepatocellular carcinoma: a case report. J Am Soc Echocardiogr (1995) 1.02
Evolution of the Texas Heart Institute Distant Organ Procurement Program. Tex Heart Inst J (1984) 1.01
Sarcoma metastatic to the right ventricle: surgical intervention followed by prolonged survival. Tex Heart Inst J (2004) 1.01
Implantation of the permanent Jarvik-2000 left-ventricular-assist-device: surgical technique. Eur J Cardiothorac Surg (2002) 1.00
Surgical management of patients in the REMATCH trial. Ann Thorac Surg (2003) 1.00
Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation. J Heart Lung Transplant (2011) 0.99
Mechanical circulatory support and cardiac transplantation. Circulation (1998) 0.99
Surgical closure of left ventricular outflow tract after left ventricular assist device implantation in patients with aortic valve pathology. J Heart Lung Transplant (2010) 0.98
Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy. J Thorac Cardiovasc Surg (2006) 0.98
Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol (1997) 0.98
Frequency and significance of infections in patients receiving prolonged LVAD support. ASAIO Trans (1992) 0.98
A felt plug simplifies left ventricular assist device removal after successful bridge to recovery. J Heart Lung Transplant (2007) 0.98
Surgical treatment of aneurysms of the transverse aortic arch: experience with 25 patients using hypothermic techniques. Ann Thorac Surg (1981) 0.97
Morphologic changes in the aortic wall media after support with a continuous-flow left ventricular assist device. J Heart Lung Transplant (2013) 0.97
Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg (1997) 0.97
Percutaneous ventricular assist device support in a patient with a postinfarction ventricular septal defect. Tex Heart Inst J (2008) 0.97
HeartMate VE LVAS design enhancements and its impact on device reliability. Eur J Cardiothorac Surg (2004) 0.97
The effect of coronary bypass on the outcome of peripheral vascular operations in 1093 patients. J Vasc Surg (1986) 0.96
Resection of aortic arch aneurysms: a comparison of hypothermic techniques in 60 patients. Ann Thorac Surg (1983) 0.96
Usefulness of percutaneous left ventricular assist device as a bridge to recovery from myocarditis. Am J Cardiol (2007) 0.96
Clinical applications of the supraceliac aorta: anatomical and pathologic observations. J Thorac Cardiovasc Surg (1987) 0.95
Cardiac transplantation: current results at the Texas heart institute. Tex Heart Inst J (1984) 0.95
Clinical experience with textured blood contacting surfaces in ventricular assist devices. ASAIO Trans (1987) 0.94
Brachiocephalic reconstruction II: operative and endovascular management of single-vessel disease. J Vasc Surg (2005) 0.94
In vivo evaluation of a peripheral vascular access axial flow blood pump. ASAIO Trans (1989) 0.94